Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. It was formerly known as H&Q Life Sciences Investors fund. Tekla Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.
IPO Year: 1992
Exchange: NYSE
Website: teklacap.com/hql.html
| Date | Price Target | Rating | Analyst |
|---|
N-CSRS - abrdn Life Sciences Investors (0000884121) (Filer)
N-CEN - abrdn Life Sciences Investors (0000884121) (Filer)
N-CSR - abrdn Life Sciences Investors (0000884121) (Filer)
N-PX - abrdn Life Sciences Investors (0000884121) (Filer)
N-CSRS - abrdn Life Sciences Investors (0000884121) (Filer)
NPORT-P - abrdn Life Sciences Investors (0000884121) (Filer)
DEFA14A - abrdn Life Sciences Investors (0000884121) (Filer)
DEF 14A - abrdn Life Sciences Investors (0000884121) (Filer)
NPORT-P - abrdn Life Sciences Investors (0000884121) (Filer)
N-CEN - abrdn Life Sciences Investors (0000884121) (Filer)
PHILADELPHIA, PA / ACCESSWIRE / March 21, 2024 / abrdn Healthcare Investors (NYSE:HQH), abrdn Life Sciences Investors (NYSE:HQL), abrdn Healthcare Opportunities Fund (NYSE:THQ), and abrdn World Healthcare Fund (NYSE:THW) (collectively, the "Funds") each, a closed-end management investment company, announced today the appointment of Dr. Jason Akus as co-lead portfolio manager to the Funds alongside Dr. Daniel Omstead. Dr. Akus has served on the investment team with Dr. Omstead for over 20 years.The Funds will continue to be managed in accordance with their existing investment objectives and strategies, pursuing the same investment philosophy and employing the same investment process that has